PLC
FLGT icon

Peapod Lane Capital’s Fulgent Genetics FLGT Stock Holding History

Peapod Lane Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.6M Buy
224,207
+3,580
+2% +$60.7K 3.1% 5
2026
Q1 		$3.49M Buy
220,627
+54,846
+33% +$1.19M 2.86% 6
2025
Q4 		$4.36M Buy
165,781
+1,202
+0.7% +$31.2K 3.71% 4
2025
Q3 		$3.72M Buy
164,579
+1,810
+1% +$37.3K 3.33% 7
2025
Q2 		$3.24M Buy
162,769
+542
+0.3% +$10.6K 3.24% 6
2025
Q1 		$2.74M Buy
162,227
+52,768
+48% +$899K 3.08% 8
2024
Q4 		$2.02M Buy
+109,459
New +$2.14M 2% 18

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Peapod Lane Capital's FLGT Position: Q2 2026 in Review

Peapod Lane Capital increased its Fulgent Genetics (FLGT) stake by 1.6% in Q2 2026, buying an estimated $60.7K and bringing the position to 224,207 shares worth $4.6M. The position accounts for 3.1% of the portfolio, ranked #5.

Peapod Lane Capital first reported a position in FLGT in Q4 2024 and has held it in 7 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Peapod Lane Capital held 224,207 shares of Fulgent Genetics worth $4.6M as of Q2 2026.
  • Peapod Lane Capital bought 3,580 Fulgent Genetics shares in Q2 2026, an estimated $60.7K.
  • Fulgent Genetics made up 3.1% of Peapod Lane Capital's portfolio in Q2 2026, its #5 holding.
  • Peapod Lane Capital first reported a position in Fulgent Genetics in Q4 2024 and has held it in 7 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Peapod Lane Capital's 13F filing for Q2 2026, filed 27 Jul 2026.